questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Protéines angiogéniques
Protéines angiostatiques
Protéines angiostatiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines angiostatiques : Questions médicales les plus fréquentes",
"headline": "Protéines angiostatiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines angiostatiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-11",
"dateModified": "2025-05-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines angiostatiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines angiogéniques",
"url": "https://questionsmedicales.fr/mesh/D042501",
"about": {
"@type": "MedicalCondition",
"name": "Protéines angiogéniques",
"code": {
"@type": "MedicalCode",
"code": "D042501",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Angiostatines",
"alternateName": "Angiostatins",
"url": "https://questionsmedicales.fr/mesh/D043168",
"about": {
"@type": "MedicalCondition",
"name": "Angiostatines",
"code": {
"@type": "MedicalCode",
"code": "D043168",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.100.450.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Endostatines",
"alternateName": "Endostatins",
"url": "https://questionsmedicales.fr/mesh/D043169",
"about": {
"@type": "MedicalCondition",
"name": "Endostatines",
"code": {
"@type": "MedicalCode",
"code": "D043169",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.100.450.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines angiostatiques",
"alternateName": "Angiostatic Proteins",
"code": {
"@type": "MedicalCode",
"code": "D043165",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Carolyn G Chen",
"url": "https://questionsmedicales.fr/author/Carolyn%20G%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Anatomy, and Cell Biology and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107."
}
},
{
"@type": "Person",
"name": "Renato V Iozzo",
"url": "https://questionsmedicales.fr/author/Renato%20V%20Iozzo",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Anatomy, and Cell Biology and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 renato.iozzo@jefferson.edu."
}
},
{
"@type": "Person",
"name": "Catherine E Simpson",
"url": "https://questionsmedicales.fr/author/Catherine%20E%20Simpson",
"affiliation": {
"@type": "Organization",
"name": "Dept of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA."
}
},
{
"@type": "Person",
"name": "Megan Griffiths",
"url": "https://questionsmedicales.fr/author/Megan%20Griffiths",
"affiliation": {
"@type": "Organization",
"name": "Dept of Pediatrics, Division of Pediatric Cardiology, Johns Hopkins University, Baltimore, MD, USA."
}
},
{
"@type": "Person",
"name": "Jun Yang",
"url": "https://questionsmedicales.fr/author/Jun%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Dept of Pediatrics, Division of Pediatric Cardiology, Johns Hopkins University, Baltimore, MD, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Artificial intelligence software in pulmonary nodule assessment.",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/36369818",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/14782715221123856"
}
},
{
"@type": "ScholarlyArticle",
"name": "A refactoring categorization model for software quality improvement.",
"datePublished": "2023-11-02",
"url": "https://questionsmedicales.fr/article/37917752",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0293742"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bioimage informatics: Investing in software usability is essential.",
"datePublished": "2023-07-31",
"url": "https://questionsmedicales.fr/article/37523379",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pbio.3002213"
}
},
{
"@type": "ScholarlyArticle",
"name": "The CCP4 suite: integrative software for macromolecular crystallography.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37259835",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1107/S2059798323003595"
}
},
{
"@type": "ScholarlyArticle",
"name": "The impact of software updates on accuracy of intraoral scanners.",
"datePublished": "2023-04-15",
"url": "https://questionsmedicales.fr/article/37061664",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12903-023-02926-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines angiogéniques",
"item": "https://questionsmedicales.fr/mesh/D042501"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines angiostatiques",
"item": "https://questionsmedicales.fr/mesh/D043165"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines angiostatiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines angiostatiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines angiostatiques",
"description": "Comment diagnostiquer une dysrégulation angiostatique ?\nQuels examens sont utilisés pour évaluer les protéines angiostatiques ?\nLes imageries médicales aident-elles au diagnostic ?\nQuels marqueurs biologiques sont associés aux protéines angiostatiques ?\nPeut-on détecter les protéines angiostatiques dans le sang ?",
"url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Software&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines angiostatiques",
"description": "Quels symptômes indiquent une dysfonction angiostatique ?\nLes troubles de la vision sont-ils liés aux protéines angiostatiques ?\nComment les protéines angiostatiques affectent-elles la peau ?\nY a-t-il des symptômes systémiques associés ?\nLes douleurs articulaires peuvent-elles être liées ?",
"url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Software&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines angiostatiques",
"description": "Comment prévenir les troubles liés aux protéines angiostatiques ?\nL'exercice physique aide-t-il à prévenir ces troubles ?\nY a-t-il des aliments à privilégier ?\nLe tabagisme influence-t-il la santé angiostatique ?\nLe stress a-t-il un impact sur l'angiogenèse ?",
"url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Software&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines angiostatiques",
"description": "Quels traitements ciblent les protéines angiostatiques ?\nLes traitements sont-ils efficaces contre le cancer ?\nY a-t-il des effets secondaires aux traitements ?\nLes traitements sont-ils personnalisés ?\nDes thérapies complémentaires sont-elles recommandées ?",
"url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Software&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines angiostatiques",
"description": "Quelles complications peuvent survenir avec une dysrégulation ?\nLes maladies cardiovasculaires sont-elles liées ?\nY a-t-il un lien avec les maladies rénales ?\nLes complications neurologiques sont-elles possibles ?\nComment les complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Software&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines angiostatiques",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe diabète est-il un facteur de risque ?\nLe mode de vie sédentaire est-il un risque ?",
"url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Software&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysrégulation angiostatique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies peuvent aider à évaluer l'angiogenèse."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les protéines angiostatiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunohistochimie et les dosages ELISA sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les imageries médicales aident-elles au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IRM et l'échographie peuvent visualiser les anomalies vasculaires."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont associés aux protéines angiostatiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme le VEGF et l'angiostatine sont souvent mesurés."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les protéines angiostatiques dans le sang ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines protéines peuvent être quantifiées dans le sérum."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dysfonction angiostatique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs, des œdèmes ou des troubles de la circulation peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision sont-ils liés aux protéines angiostatiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une angiogenèse anormale peut causer des troubles visuels."
}
},
{
"@type": "Question",
"name": "Comment les protéines angiostatiques affectent-elles la peau ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des lésions cutanées dues à une circulation sanguine altérée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue ou la fièvre peuvent survenir dans certains cas."
}
},
{
"@type": "Question",
"name": "Les douleurs articulaires peuvent-elles être liées ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une mauvaise circulation peut entraîner des douleurs articulaires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux protéines angiostatiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée, est recommandé."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir ces troubles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine et la santé vasculaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des aliments à privilégier ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des aliments riches en antioxydants, comme les fruits et légumes, sont bénéfiques."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la santé angiostatique ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme nuit à la circulation et favorise les troubles angiostatiques."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur l'angiogenèse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber l'équilibre angiostatique."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les protéines angiostatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des médicaments anti-angiogéniques sont utilisés."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces contre le cancer ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les inhibiteurs de l'angiogenèse sont utilisés dans certains cancers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets comme l'hypertension ou des saignements peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être adaptés selon le type de cancer et le patient."
}
},
{
"@type": "Question",
"name": "Des thérapies complémentaires sont-elles recommandées ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches comme l'acupuncture peuvent être envisagées en complément."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une dysrégulation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des thromboses ou des hémorragies peuvent se produire."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles liées ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une mauvaise régulation angiostatique peut augmenter le risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien avec les maladies rénales ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles angiostatiques peuvent affecter la fonction rénale."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la circulation peuvent entraîner des complications neurologiques."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent réduire la qualité de vie en limitant les activités quotidiennes."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme et l'hypertension sont des facteurs de risque majeurs."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge en raison de la dégradation vasculaire."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies vasculaires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut altérer la régulation angiostatique et augmenter les complications."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire contribue à une mauvaise santé vasculaire."
}
}
]
}
]
}
This study tests the impact of the addition of autonomous computed tomography (CT) interpreting software to radiologist assessment of pulmonary nodules....
Computed tomography scans for nodule assessment were identified retrospectively. Lung cancer risk factors, initial radiologist (RAD) report, Philips Lung Nodule software report (computer-aided nodule ...
In all, 100 patients were studied. Median maximal diameter of the largest nodule reported by RAD and RAD + CAD were similar at 10.0 and 9.0 mm, respectively (...
This study suggests that autonomous software use can alter radiologist assessment of pulmonary nodules such that suggested follow-up is altered....
Refactoring, a widely adopted technique, has proven effective in facilitating and reducing maintenance activities and costs. Nonetheless, the effects of applying refactoring techniques on software qua...
In 2018, PLOS Biology announced CellProfiler 3.0, which has become one of the most used pieces of image analysis software in biology. The rapid adoption of this software speaks to the importance of us...
The Collaborative Computational Project No. 4 (CCP4) is a UK-led international collective with a mission to develop, test, distribute and promote software for macromolecular crystallography. The CCP4 ...
Digital workflow is showing an increasing tendency in everyday dentistry. Accuracy is essential during digital dental workflows for all indication areas. The present study aimed to evaluate the effect...
3Shape Trios 3 Pod with software versions 18.1.2. (TRI3_1) and 20.1.2. (TRI3_2); 3Shape Trios 4 Move, version 19.2.2. (TRI4_1); and 3Shape Trios 4 Pod, version 20.1.1. (TRI4_2) were used to take direc...
In parameter 1 and 2, the newest model with the latest software (TRI4_2) reached the highest accuracy (31.06 ± 5.24 µm and 21.69 ± 7.50 µm). In parameter 3, an older generation scanner running legacy ...
Appropriate software updates can significantly increase the trueness and precision of intraoral scanner devices. With updated software, the older generation can match the accuracy level of latest equi...
The development of robotic applications necessitates the availability of useful, adaptable, and accessible programming frameworks. Robotic, IoT, and sensor-based systems open up new possibilities for ...
Metagenomic experiments expose the wide range of microscopic organisms in any microbial environment through high-throughput DNA sequencing. The computational analysis of the sequencing data is critica...
Different software programs are available for the evaluation of 4D Flow cardiovascular magnetic resonance (CMR). A good agreement of the results between programs is a prerequisite for the acceptance o...
Eight healthy subjects (27 ± 3 years, 3 women) were each examined on two 3T CMR systems (Ingenia, Philips Healthcare; MAGNETOM Skyra, Siemens Healthineers) with a standardized 4D Flow CMR sequence. Si...
SW-A and SW-C were the only software programs showing agreement for stroke volume (ICC = 0.96; E...
Of all tested software programs, only SW-A and SW-C can be used equivalently for determination of stroke volume, peak flow, and vessel area. Irrespective of the applied software and scanner, high intr...
Computed tomography perfusion (CTP) has played an important role in patient selection for mechanical thrombectomy (MT) in acute ischemic stroke. We aimed to investigate the agreement between perfusion...
We retrospectively reviewed a prospectively maintained MT database to identify patients with anterior circulation large vessel occlusion strokes (LVOS) involving the internal carotid artery or middle ...
In this analysis of 242 patients with LVOS, RAPID and Viz CTP relative cerebral blood flow (rCBF) < 30% values had substantial agreement (ρ = 0.767 [95% confidence interval [CI] = 0.71-0.81]) as well ...
Perfusion parametric maps of the RAPID, Viz CTP, and e-CTP software have substantial agreement in predicting final infarct volume in near-completely/completely reperfused patients. ANN NEUROL 2023;94:...
The MAGIX code (a French acronym standing for Automatic Gamma and X-ray Measurement) is a software developed to analyze γ/X spectra on the topic of severe accident diagnosis. Indeed, the gamma spectra...